RecruitingNot ApplicableNCT06305741
A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers
Managing Anxiety From Cancer (MAC): Evaluation of a Tailored Anxiety Intervention for Latino Older Adults With Cancer and Their Caregivers
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
60 participants
Start Date
Mar 5, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to find out if an anxiety treatment program is practical and effective for Latino older adults with cancer (OACs) and their caregivers.
Eligibility
Min Age: 40 Years
Inclusion Criteria14
- Older Adults with Cancer (OAC)
- As per medical record or self-report, is currently age 65 years or older
- As per medical record or self-report, currently receiving active cancer treatment OR is within eighteen months of completing active treatment which includes surgery, chemotherapy, radiation, and immunotherapy.
- As per self-report, identifies as Latino and/or Hispanic Ethnicity
- Scores ≥6 on the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS)
- Per self-report, fluent in English and/or Spanish\*\* \*\* Language verification: Prior to enrollment, patients will be asked the following two questions by a Clinical Research Coordinator (CRC) to verify language fluency necessary for participation in the study:
- How well do you speak English and/or Spanish? (must respond "very well" or "well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused)
- What is your preferred language for healthcare? (must respond English and/or Spanish)
- Caregiver
- Per OAC report, is primary informal caregiver (as defined by an unpaid individual who provides the patient with emotional, physical, and/or practical support) for the eligible OAC patient
- As per self-report, is age 40 years or older
- Per self-report, fluent in English and/or Spanish\*\* \*\* Language verification: Prior to enrollment, patients will be asked the following two questions by a Clinical Research Coordinator (CRC) to verify language fluency necessary for participation in the study:
- How well do you speak English and/or Spanish? (must respond "very well" or "well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused)
- What is your preferred language for healthcare? (must respond English and/or Spanish)
Exclusion Criteria13
- OAC
- As per medical record or self-report, currently receiving psychotherapy
- As per medical record or self-report, taking psychotropic medications for \< 8 weeks prior to MAC Session 1 and/or anticipates changing their medication during the study
- As per medical record or self-report, currently being treated for schizophrenia, substance use or dependence, and/or bi-polar disorder
- Severely cognitively impaired as demonstrated by Blessed Orientation Memory Concentration score ≥ 11
- Per research staff judgment and/or self-report, too ill or weak to complete study procedures
- Per medical record or self-report, receiving hospice care at the time of enrollment
- Caregiver
- As per self-report, currently receiving psychotherapy
- As per self-report, taking psychotropic medications for \< 8 weeks prior to MAC Session 1 and/or anticipates changing their medication during the study
- As per self-report, currently being treated for schizophrenia, substance use or dependence, and/or bi-polar disorder
- Severely cognitively impaired as demonstrated by Blessed Orientation Memory Concentration score ≥ 11
- Per research staff judgment and/or self-report, too ill or weak to complete study procedures
Interventions
OTHERManaging Anxiety from Cancer (MAC)
The intervention, MAC, is a seven-session (45-60 minutes per session) psychotherapy intervention delivered via videoconference and/or telephone by licensed social workers OR at least a Master's level (or enrolled in a doctorate program) advanced trainees in mental health fields.
Locations(7)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06305741